期刊文献+

大肠杆菌K5产肝素前体heparosan的研究进展 被引量:5

Progress of Study on the Heparoson Production by E.coli K5
下载PDF
导出
摘要 肝素是一种被广泛临床应用的抗凝血药物多糖。Heparosan是某些细菌荚膜中的GAG成分,其二糖骨架结构与脊椎动物中的肝素类似,可以作为肝素和硫酸乙酰肝素的生物合成前体。本文综述了肝素及肝素前体heparosan的功能与应用,heparosan在大肠杆菌K5中合成转运相关酶的研究,以及发酵法生产heparosan的研究进展,并对其应用前景进行了展望。 Heparin is a widely used drug polysaccharide for anticoagulant in clinical application.Heparosan,a composition of GAG in some bacteria capsular,has the same disaccharide backbone structure as that in vertebrate,and can be used as precurosor of heparin and heparan sulfate biosynthesis.This article reviewes the function and application of heparin and heparosan,the progress of study on the enzymes related to heparosan synthesis and transformation in E.coli K5,the preparation of heparosan by fermentation,and the application prospect of heparosan.
出处 《生物技术进展》 2011年第3期195-200,共6页 Current Biotechnology
基金 国家自然科学基金项目(21076195)资助
关键词 HEPAROSAN 大肠杆菌K5 肝素 发酵生产 heparosan E.coli K5 heparin fermentation
  • 相关文献

参考文献28

  • 1Rosario Mu?oz,Ernesto García,Rubens López.Evidence for horizontal transfer from streptococcus to escherichia coli of the kfid gene encoding the K5-specific UDP-glucose dehydrogenase[J]. Journal of Molecular Evolution . 1998 (4)
  • 2Linhardt R J,Gunay N S.Production and chemical processing of low molecular weight heparins. Seminars in Thrombsis and Hemostasis . 1999
  • 3Kishimoto T K,Viswanathan K,Ganguly Tet al.Contami-nated heparin associated with adverse clinical events and activation of the contact system. The New England Journal of Medicine . 2008
  • 4Wang Z Y,Ly M,Zhang F Met al.E.coli K5fermentation and the preparation of heparosan,a bioengineered heparin precursor. Biotechnology and Bioengineering . 2010
  • 5Alfonso B,Vlodavsky I,Haloun Cet al.Synthesis and heparin-like biological activity of amino acid-based polymers. Polymer.Adv.Technol . 2000
  • 6Deangelis P L.Microbial glycosaminoglycan glycosyltrans-ferases. Glycobiology . 2002
  • 7Petit C,Rigg G P,Pazzani C,et al.Region-2of the Escherichia coli K5capsule gene-cluster encoding proteins for the biosynthesis of the K5polysaccharide. Molecular Microbiology . 1995
  • 8Corbett D,Roberts I S.Capsular polysaccharides in Escherichia coli. Adv.Appl.Microbiol . 2008
  • 9Taylor C M,Roberts I S.Bacterial capsules:a route for poly-saccharide engineering. Handbook of Carbohydrate Engineering . 2005
  • 10Sugiura N,Baba Y,Kawaguchi Yet al.Glucuronyltrans-ferase activity of KfiC from Escherichia coli strain K5requires association of KfiA.KfiC and KfiA are essentlal enzymes for production of K5polysaccharide,N-acetylheparosan. Journal of Biological Chemistry . 2010

同被引文献63

  • 1边玲.多糖命名法[J].食品与药品,2010,12(11):455-457. 被引量:1
  • 2BishOp J R, Schuksz M, Esk0 J D. Heparan sulphate proteoglycans fine-tune mammalian physiology[J]. Nature, 2007,446 (4) : 1030- 1037.
  • 3Linhardt R J,Toida T. Role of glycosaminoglycans in celhilar co- mmunication[J]. Account of Chemical Research, 2004, 37 (7)I 431-438.
  • 4Rabenstein D L. Heparin and heparan sulfate:Structure and func- tion[J]. Natural Product Reports,2002,19(3) :312-331.
  • 5Kovensky J. Sulfated oligosaccharides : New targets for drug devel- opment[J]. Curt Med Chem,2009,16(6) :2338-2344.
  • 6Gandhi N S,Mancera R L. Heparin/heparan sulphate-based drugs [J]. Drug Discovery Today,2010,15(23-24) : 1058-1069.
  • 7Liu H,Zhang Z,Linhardt R J. Lessons learned from the contami- nation of heparin[J]. Natural Product Reports, 2009,26 ( 3 ) : 313-321.
  • 8Guerrini M, Beccati D, Shriver Z, et al. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events[J]. Nature Biotechnology,2008,26(4) :669-675.
  • 9Silbert J E,Sugumaran G. A starting place for the road to func- tion[J] Glycoconj ugate Journal, 2002,19 (4) : 227-237.
  • 10Esko J D, Selleck S B. Order out of chaos: Assembly of ligand binding sites in heparan sulfate[J]. Annual Review of Nochemis- try,2002,71(7) :435-471.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部